New TB cocktail shows promise in early trial
Disease control
Completed
This study tested a new drug called delpazolid, given with three standard TB medicines, to see if it is safe and works better than the standard drugs alone. 76 adults with newly diagnosed, drug-sensitive tuberculosis took part. The goal was to find the best dose and understand ho…
Phase: PHASE2 • Sponsor: LigaChem Biosciences, Inc. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC